Kupando

GermanySchönefeldBiotech & PharmaSeries A

Overview

Where Kupando is now

Kupando announced a Series A round of €10M on 18 March 2026, led by Remiges Ventures.

Observed Described in the funding announcement as "biotech company developing therapies for cancer and infectious diseases". Source

Latest round
Series A
Amount
€10M
Announced
18 March 2026
Headquarters
Schönefeld, Germany
Sector
Biotech & Pharma
Investors
Remiges Ventures
Also participating
Brandenburg Kapital, High-Tech Gründerfonds, Ventura Biomed Investors and Carma Fund The raise brought the total amount to $23M
Relevant leadership
CEO and Founder Johanna Holldack

Current direction Inferred

What this company is working on

Research and development

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

45
Steady growth
0 funding signals in the last 90 days
Funding recency
18/40
announced within the last 6 months
Round scale
12/25
round size relative to the market
Funding stage
15/20
Series A
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 18 March 2026
    €10M Series A
    Led by Remiges Ventures.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Kupando from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Kupando

Not yet specified

Kupando has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Kupando.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector